368 related articles for article (PubMed ID: 20858388)
21. Epiluminescence microscopy (dermoscopy) versus visual inspection during Mohs microscopic surgery of infiltrative basal cell carcinoma.
Gurgen J; Gatti M
Dermatol Surg; 2012 Jul; 38(7 Pt 1):1066-9. PubMed ID: 22676346
[TBL] [Abstract][Full Text] [Related]
22. [Mohs surgery for basal cell carcinoma].
Glud M; Omland SH; Paoli J; Gniadecki R
Ugeskr Laeger; 2017 Feb; 179(6):. PubMed ID: 28397683
[TBL] [Abstract][Full Text] [Related]
23. An educational device for Mohs micrographic surgery. A three-dimensional model of basal cell carcinoma.
Leffell DJ
J Dermatol Surg Oncol; 1991 Jun; 17(6):498-501. PubMed ID: 2040753
[TBL] [Abstract][Full Text] [Related]
24. [Mohs micrographic surgery for the treatment of basal cell carcinoma].
Galimberti G; Pontón Montaño A; Ferrario D; Kowalczuk A; Galimberti R
Actas Dermosifiliogr; 2010 Dec; 101(10):853-7. PubMed ID: 21159261
[TBL] [Abstract][Full Text] [Related]
25. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
[TBL] [Abstract][Full Text] [Related]
26. Association between number of stages in Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study of practice patterns of 20 early- and mid-career Mohs surgeons.
Alam M; Berg D; Bhatia A; Cohen JL; Hale EK; Herman AR; Huang CC; Jiang SI; Kimyai-Asadi A; Lee KK; Levy R; Rademaker AW; White LE; Yoo SS
Dermatol Surg; 2010 Dec; 36(12):1915-20. PubMed ID: 21040123
[TBL] [Abstract][Full Text] [Related]
27. [Microcystic adnexal carcinoma: Mohs micrographic surgery as the treatment of choice].
Martorell-Calatayud A; Requena-Caballero C; Botella-Estrada R; Almenar-Medina S; Sanmartín-Jiménez O; Llombart-Cussac B; Nagore-Enguídanos E; Serra-Guillén C; Echeverría-García B; Guillén-Barona C
Actas Dermosifiliogr; 2009 Oct; 100(8):693-9. PubMed ID: 19775547
[TBL] [Abstract][Full Text] [Related]
28. Mohs micrographic surgery.
Thomas RM; Amonette RA
Am Fam Physician; 1988 Mar; 37(3):135-42. PubMed ID: 3348115
[TBL] [Abstract][Full Text] [Related]
29. Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance.
Sebaratnam DF; Choy B; Lee M; Paver R; Fernández Peñas P
Dermatol Surg; 2016 May; 42(5):633-8. PubMed ID: 27110895
[TBL] [Abstract][Full Text] [Related]
30. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
[TBL] [Abstract][Full Text] [Related]
31. Recurrence of basosquamous carcinoma after Mohs micrographic surgery.
Skaria AM
Dermatology; 2010; 221(4):352-5. PubMed ID: 20924160
[TBL] [Abstract][Full Text] [Related]
32. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
33. Mohs micrographic surgery: a synopsis.
Stone JL
Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
[TBL] [Abstract][Full Text] [Related]
34. Cost Analysis of Mohs Micrographic Surgery in High-Risk Facial Basal Cell Carcinoma.
Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
Actas Dermosifiliogr; 2010 Sep; 101(7):622-628. PubMed ID: 28709544
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
36. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
[TBL] [Abstract][Full Text] [Related]
37. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
[TBL] [Abstract][Full Text] [Related]
38. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of Mohs' micrographic surgery in two English centres.
Julian CG; Bowers PW
Br J Dermatol; 1997 Apr; 136(4):515-8. PubMed ID: 9155950
[TBL] [Abstract][Full Text] [Related]
40. Determining the value of surgical therapies for basal cell carcinoma.
Chren MM
Arch Dermatol; 2006 Feb; 142(2):231-2. PubMed ID: 16490852
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
